This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Comment: Twitter's pitched regulatory battle with US FTC revealed in deposition by auditor

By Mike Swift ( July 21, 2023, 19:57 GMT | Comment) -- A thicket of documents made public by Twitter in a recent court filing, including a 220-page deposition of Ernst & Young partner David Roque, reveals the regulatory confrontation between the social media company headed by Elon Musk and the US Federal Trade Commission under Chair Lina Khan. Roque’s testimony illuminates both the chaos within Twitter after Musk bought the San Francisco-based company and the pressure the FTC put on Ernst & Young to corroborate evidence the regulator said it had about Twitter’s privacy and data security failures.A money-bleeding social media company newly acquired by mercurial billionaire Elon Musk, where the leadership structure was collapsing as senior leadership quit or was fired. An aggressive regulator with evidence of improper conduct bent on confirming that conduct through an independent audit....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login